HGF/c-Met Axis Drives Cancer Aggressiveness in the Neoadjuvant Setting of Ovarian Cancer

Gynecologic Oncology - United States
doi 10.1016/j.ygyno.2014.03.255
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Therapeutic Potential of Targeting the HGF/cMET Axis in Ovarian Cancer

Molecular Diagnosis and Therapy
MedicineMolecular MedicineGeneticsPharmacology
2016English

Targeting the HGF/c-Met Axis: State of Play

Molecular Cancer Therapeutics
Cancer ResearchOncology
2010English

HGF-independent Regulation of MET and GAB1 by Nonreceptor Tyrosine Kinase FER Potentiates Metastasis in Ovarian Cancer

Genes and Development
GeneticsDevelopmental Biology
2016English

HGF/Met Signaling in Cancer Invasion: The Impact on Cytoskeleton Remodeling

Cancers
Cancer ResearchOncology
2017English

Targeting the HGF/c-MET Pathway in Hepatocellular Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2013English

HGF and C-Met in Pathogenesis of Endometrial Carcinoma

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

Mechanisms of HGF/Met Signaling to BRK and Sam68 in Breast Cancer Progression

Hormones and Cancer
OncologyCancer ResearchEndocrinologyAutonomic SystemsEndocrineMetabolismDiabetes
2011English

Hepatocyte Growth Factor/C-Met Axis in Thyroid Cancer: From Diagnostic Biomarker to Therapeutic Target

Biomarker Insights
BiochemistryMolecular MedicinePharmacology
2017English

Recent Progress and Advances in HGF/MET-Targeted Therapeutic Agents for Cancer Treatment

Biomedicines
BiochemistryMedicineGeneticsMolecular Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy